Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Changchun Baohua Pharmaceutical is a comprehensive pharmaceutical enterprise located in Changchun, China, specializing in the research, production, and distribution of chemical and traditional Chinese medicines. The company is best known for its respiratory and cold-relief products, particularly its flagship brand Keling, which is widely distributed across the Chinese retail pharmacy market. Operating out of the Changchun High-tech Industrial Development Zone, the firm maintains multiple GMP-certified production lines for various dosage forms including capsules, tablets, and granules. Baohua Pharmaceutical focuses on providing affordable, high-quality essential medicines to address common health conditions such as influenza, cardiovascular issues, and nutritional deficiencies. The company has established a strong presence in the domestic Chinese market through a robust sales network and a commitment to manufacturing excellence.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Changchun Baohua Pharmaceutical.